Dr. Brightwell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2004 Hayes St Ste 205
Nashville, TN 37203Phone+1 615-284-4646Fax+1 615-284-7501
Education & Training
- University at BuffaloFellowship, Gynecologic Oncology, 2012 - 2016
- NYU Grossman School of Medicine/Brooklyn CampusResidency, Obstetrics and Gynecology, 2008 - 2012
- St. George's University School of MedicineClass of 2008
Certifications & Licensure
- TN State Medical License 2022 - 2026
- TX State Medical License 2016 - 2023
- NY State Medical License 2012 - 2018
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Publications & Presentations
PubMed
- 1 citationsUse of hematologic biomarkers during chemotherapy predicts survival in ovarian cancer patientsRachel Brightwell, Kevin H. Eng, Shashikant Lele
European Journal of Gynaecological Oncology. 2017-01-01 - 49 citationsThe CD47 “don't eat me signal” is highly expressed in human ovarian cancerRachel Brightwell, K.S. Grzankowski, Shashikant Lele, Kevin H. Eng, Mohd Arshad
Gynecologic Oncology. 2016-11-01 - 1 citationsDocetaxel and nab-paclitaxel are safe alternative options for patients with gynecologic malignancies following hypersensitivity reaction to paclitaxel.Rachel Brightwell, E. Handel, Kevin H. Eng, K.S. Grzankowski, Peter J. Frederick
European Journal of Gynaecological Oncology. 2016-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: